Cardiovascular Therapeutics

Scope & Guideline

Connecting Knowledge and Practice in Cardiology

Introduction

Welcome to the Cardiovascular Therapeutics information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Cardiovascular Therapeutics, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1755-5914
PublisherWILEY-HINDAWI
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2008 to 2024
AbbreviationCARDIOVASC THER / Cardiovasc. Ther.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON WIT 5HE, ENGLAND

Aims and Scopes

Cardiovascular Therapeutics aims to advance the field of cardiovascular medicine through innovative research, clinical trials, and therapeutic advancements. The journal focuses on a wide range of topics related to cardiovascular diseases, therapies, and health outcomes, providing a platform for researchers and clinicians to share their findings.
  1. Cardiovascular Risk Assessment and Management:
    The journal publishes studies focusing on the assessment of cardiovascular risk factors, including novel biomarkers and risk prediction models, to enhance the management and prevention of cardiovascular diseases.
  2. Therapeutic Interventions and Clinical Trials:
    A significant emphasis is placed on clinical trials evaluating the efficacy and safety of new therapeutic interventions, including pharmacological treatments, surgical procedures, and lifestyle modifications.
  3. Pathophysiology and Mechanistic Insights:
    Research articles delve into the underlying mechanisms of cardiovascular diseases, exploring cellular and molecular pathways that contribute to conditions such as myocardial infarction, heart failure, and atherosclerosis.
  4. Rehabilitation and Exercise Therapy:
    The journal highlights studies that assess the role of rehabilitation strategies, including exercise therapy and lifestyle interventions, in improving outcomes for patients with cardiovascular conditions.
  5. Emerging Therapies and Natural Products:
    There is a growing interest in the exploration of natural products and alternative therapies for cardiovascular diseases, with studies investigating their potential therapeutic roles and mechanisms of action.
  6. Public Health and Epidemiological Studies:
    Cardiovascular Therapeutics also prioritizes research addressing public health aspects, epidemiological trends, and the socioeconomic impact of cardiovascular diseases.
Recent publications in Cardiovascular Therapeutics have highlighted several trending and emerging themes that reflect the evolving landscape of cardiovascular research. These themes are gaining traction and may represent future directions for the field.
  1. Biomarkers for Cardiovascular Diseases:
    An increasing number of studies focus on identifying and validating novel biomarkers for cardiovascular diseases, particularly in heart failure and atherosclerosis, which can enhance early diagnosis and treatment.
  2. Impact of COVID-19 on Cardiovascular Health:
    Research examining the implications of COVID-19 on cardiovascular health, including the effects of viral infections on existing cardiovascular conditions, has surged, showcasing the pandemic's influence on cardiovascular research.
  3. Integrative and Holistic Approaches to Treatment:
    Emerging interest in integrative therapies, such as meditation, yoga, and lifestyle modifications, reflects a trend towards holistic approaches to cardiovascular health, emphasizing the importance of mental and physical well-being.
  4. Advanced Imaging Techniques and Diagnostics:
    There is a notable trend towards the utilization of advanced imaging techniques for better diagnosis and management of cardiovascular diseases, facilitating more precise interventions.
  5. Artificial Intelligence and Machine Learning in Cardiovascular Research:
    The application of AI and machine learning methods in cardiovascular research is rapidly growing, particularly in risk prediction models and personalized treatment strategies, marking a significant technological advancement in the field.

Declining or Waning

While the journal continues to explore a wide array of cardiovascular topics, certain themes appear to be declining in prominence. This may reflect shifts in research focus or advancements in understanding that have led to reduced interest in specific areas.
  1. Traditional Risk Factor Studies:
    Research focusing solely on traditional cardiovascular risk factors, such as hypertension and hyperlipidemia, has decreased as newer methodologies and biomarkers gain traction in risk assessment.
  2. Pharmacogenomics in Cardiovascular Therapy:
    There has been a waning interest in studies solely dedicated to pharmacogenomic profiling for cardiovascular drug responses, possibly due to advancements in personalized medicine that integrate broader genetic and environmental factors.
  3. Basic Science Studies without Clinical Relevance:
    The journal has seen fewer submissions of basic science studies that do not translate into clinical applications, indicating a preference for research with direct implications for patient care.

Similar Journals

Clinica e Investigacion en Arteriosclerosis

Fostering collaboration in cardiology and pharmacology advancements.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Journal of the Practice of Cardiovascular Sciences

Advancing Cardiovascular Knowledge for a Healthier Tomorrow
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2395-5414Frequency: 3 issues/year

Journal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.

Acta Cardiologica Sinica

Championing Excellence in Cardiovascular Research.
Publisher: TAIWAN SOC CARDIOLOGYISSN: 1011-6842Frequency: 4 issues/year

Acta Cardiologica Sinica is a distinguished journal dedicated to the advancement of cardiology and cardiovascular medicine, published by the Taiwan Society of Cardiology. Since its inception in 1988, this journal has provided a platform for researchers and clinicians to share cutting-edge findings and insights into cardiac health, cardiovascular diseases, and innovative treatment strategies. With an impressive Q3 classification in the Cardiology category for 2023, the journal is recognized for its contributions to the field, ranked #208 out of 387 in Scopus, placing it within the 46th percentile of medical journals. Although it currently does not offer open access options, it remains a valued resource for the global cardiovascular community. The journal's commitment to disseminating high-quality research papers, reviews, and case studies ensures that it plays a vital role in improving cardiovascular health practices and outcomes. For researchers, professionals, and students alike, Acta Cardiologica Sinica is essential reading for staying informed about the latest developments in cardiology.

Aktuelle Kardiologie

Empowering healthcare professionals with cutting-edge findings.
Publisher: GEORG THIEME VERLAG KGISSN: 2193-5203Frequency: 6 issues/year

Aktuelle Kardiologie is a premier journal in the field of cardiology, published by GEORG THIEME VERLAG KG. With its ISSN 2193-5203 and E-ISSN 2193-5211, it serves as an essential resource for cardiologists, researchers, and healthcare professionals who seek to stay abreast of the latest developments in cardiovascular medicine. Although currently not open access, the journal provides comprehensive insights through its rigorous peer-review process, ensuring high-quality content for its readers. Located in Stuttgart, Germany, the journal’s objectives include fostering the exchange of innovative research, clinical findings, and expert opinions that can significantly enhance patient care and inspire further studies in cardiovascular health. In an era where cardiovascular diseases are a leading public health concern, Aktuelle Kardiologie remains a vital platform for disseminating critical knowledge and advancing the field.

American Journal of Preventive Cardiology

Leading the Charge in Preventive Cardiology Insights.
Publisher: ELSEVIERISSN: 2666-6677Frequency: 4 issues/year

American Journal of Preventive Cardiology, published by ELSEVIER, is a premier Open Access journal that has been making significant strides in the field of cardiology since its inception in 2020. With an impressive impact factor and recognized as a Q1 journal in the Cardiology and Cardiovascular Medicine category as of 2023, it ranks 77th out of 387 in the Scopus database, placing it in the 80th percentile of its field. The journal aims to promote the latest research and practices in preventive cardiology, addressing the global burden of cardiovascular diseases through a combination of innovative findings and practical applications. With the advantage of Open Access, all published articles are readily available to researchers, professionals, and students worldwide, fostering a broad dissemination of knowledge and encouraging collaboration across disciplines. Based in Amsterdam, Netherlands, the journal is committed to advancing the science and prevention of heart disease, making it an essential resource for those dedicated to improving cardiovascular health.

CIRCULATION

Leading the Charge in Heart Health Research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

CARDIOVASCULAR RESEARCH

Innovating research for a healthier heart.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

BMC Cardiovascular Disorders

Pioneering research for a healthier heart.
Publisher: BMCISSN: 1471-2261Frequency: 1 issue/year

BMC Cardiovascular Disorders is a premier open access journal dedicated to the field of cardiology and cardiovascular medicine, published by BMC, a leading publisher in the scientific community. Since its inception in 2001, this journal has provided a platform for high-quality research, showcasing innovative studies and critical reviews that contribute to the understanding and management of cardiovascular diseases. With an impressive impact factor and a rank in the Q2 category for 2023 within its field, BMC Cardiovascular Disorders stands at the forefront of cardiovascular research, enabling accessibility to a wealth of information that fosters collaboration and advancements in patient care. The journal's commitment to open access ensures that research is widely disseminated and easily accessible to researchers, practitioners, and students globally, enhancing the dialogue around cardiovascular health and disease prevention. Located in the United Kingdom, BMC Cardiovascular Disorders consistently aims to promote excellence in the study and treatment of cardiovascular conditions, encouraging the exchange of knowledge that ultimately benefits public health.

Journal of Atherosclerosis and Thrombosis

Fostering critical conversations in atherosclerosis and thrombosis.
Publisher: JAPAN ATHEROSCLEROSIS SOCISSN: 1340-3478Frequency: 12 issues/year

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology

Empowering cardiology through open access and collaboration.
Publisher: KARE PUBLISSN: 1016-5169Frequency: 8 issues/year

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.